Company Monitoring Page for ALK-Abello

latest headlines for company on cafepharma

With US launch progressing, ARS inks another licensing deal for epinephrine spray Neffy worth up to $465M
Fierce Pharma
Mon, 11/11/24 - 11:28 am
Tags:
ARS Pharmaceuticals, epinephrine, epinephrine nasal spray, ALK-Abello, Europe, Neffy
Merck Calls Time On U.S. Allergy Market
Seeking Alpha
Thu, 07/28/16 - 09:04 am
Tags:
Merck, ALK-Abello, allergies
ALK's phase III MITRA trial of new allergy immunotherapy tablet against house dust mite-induced allergic asthma meets primary endpoint
Pharmabiz
Sat, 07/13/13 - 12:41 pm
Tags:
asthma, Merck, ALK-Abello
3 Promising Treatments for a Surprisingly Common Health Problem
Motley Fool
Sun, 05/5/13 - 10:54 am
Tags:
MK-7243, allergic rhinitis, allergies, Ragweed Allergy, Merck, MK-3461, ALK-Abello
Merck says pill tames allergic response to ragweed
Reuters
Sun, 03/4/12 - 12:02 pm
Tags:
MK-3641, Merck, ALK-Abello

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.